Professor of neurology Professor at the Department of Neurology at the Faculty of Medicine in Niš. Specialist in neurology and pain medicine at the Clinic for Neurology of the University Clinic of the center of Nis He studied at the Faculty of Medicine of the University of Niš and the Faculty of Medicine University in Belgrade. He trained in the field of headache and neurological pain clinics in Athens, Rome, Leiden, London and Prague. Participant and manager of domestic i of international projects in the field of pain and headache medicine. Author of numerous chapters and of original scientific works, lecturer at domestic and international congresses, member of editorial boards and editor of eminent scientific journals. Member of international and of the National Association for Writing Guides in Headache and Pain Medicine. Winner of numerous international awards and recognitions for scientific and professional results activities.

Dr. Cho’s main research interests have been focusing on cancer studies to discover biomarkers for cancer diagnosis, treatment prediction and prognostication. As a seasoned researcher, Dr Cho hasconducted cancer research in using molecular biology, proteomics, genomics, immunology as well as bioinformatics, his current H-index is about 83. Dr. Cho has published more than 600 peer-reviewed papers (Lancet, Lancet Oncology, Annals of Oncology, Lancet Gastroenterology & Hepatology, Advanced Science, Nature Communications,PNAS,Molecular Cancer,Journal of Thoracic Oncology,Journal of the National Cancer Institute,Journal of Extracellular Vesicles, Clinical Cancer Research, Clinical Chemistry, Theranostics, etc.) covering cancer biomarkers, proteomics, non-coding RNA, traditional Chinese medicine, and dozens of books (including “An Omics Perspective on Cancer Research”, “MicroRNAs in Cancer Translational Research”, “Drug Repurposing in Cancer Therapy: Approaches and Applications”, “Supportive Cancer Care with Chinese Medicine” and “Resistance to Anti-CD20 antibodies and approaches for their reversal”, etc).

Luca Roncati, MD-PhD, DMLS, is Associate Editor of the European Journal of Gynaecological Oncology (EJGO), Medical Executive at the University Hospital of Modena, and Adjunct Professor at the University of Modena and Reggio Emilia (Italy). Eponym of the Roncati-Manenti triad and describer of T rex lymphoma, he is the author of more than 250 academic publications, he has taken part in the scientific work of various national and international agencies or research groups, he has organized several conferences of national relevance, he has attended as a speaker at numerous congresses and seminars, he holds the intellectual property of an Italian and international patent for anticancer therapy, and he has obtained various national and supranational awards.

Dr. Mihail Lucian Birsa is currently a Professor in the Department of Chemistry at the Alexandru Ioan Cuza University of Iasi, Romania. In 2003 he was selected as a member of the Alexander von Humboldt Foundation, working with Professor Henning Hopf in TU Braunschweig - Germany. Since then numerous return fellowships were granted by the Alexander von Humboldt Foundation. He has more than 125 publications in peer-review journals and published +45 books/book chapters (John Wiley & Sons, Thieme etc). Also, is editorial board member in more than 50 journals such as Applied Sciences, Arkivoc, BioChem, Edelweiss Chemical Science Journal, Journal of Medicinal Chemistry and Drug Design, Journal of Fine Chemical Engineering, Modern Approaches in Drug Designing, Pharmaceutical Toxicology.

Dr. Laura Gabriela SARBU is currently an Associate Professor in the Department of Chemistry at Alexandru Ioan Cuza University of Iasi, Romania. She received a Ph.D. degree in Organic Chemistry in 2015. During the Ph.D. program she joined several times the Prof. dr. Henning Hopf research team in TU Braunschweig – Germany. She has more than 45 publications in peer-review journals and published 4 books. Also, is editorial board member in several journals such as Advance in Medical and Clinical Research, Annals of Clinical and Laboratory Recerca, Chemical Glycobiology Journal, International Journal Bioorganic and Medicinal Chemistry, Journal of Biomedical Research & Environmental Sciences - Green Chemistry, Journal of Clinical Research and Reports, Journal of Molecular Biology and Drug Design, International Journal of Biochemistry and Pharmacology, International Journal of Pharmaceutical Sciences and Clinical Pharmacy.

Amgad Mohammed Rabie Hamed Fouda has completed his MSc and Postgraduate studies in Pharmaceutical and Biomedical Sciences at the age of 30 years from the Faculty of Pharmacy, Mansoura University, Egypt. He is one of the most famous and reputed Egyptian and Arab pharmacists, researchers and scientists. His new researches focused on the synthesis, discovery, and development of new drugs and medicines for the most resistant and untreated human diseases. He is the head of pharmacists at the Dikernis General Hospital (Mansoura, Egypt), a premier governmental hospital in Egypt. He has published more than 25 papers in very reputed journals and serving as an Editorial Board Member of great repute.

Zhenhuan LIU professor of pediatrics,Pediatricacupuncturist Ph.D.tutor.He has been engaged in pediatric clinical and child rehabilitation for 40 years. Led the rehabilitation team to treat more than 40,000 cases of children with intellectual disability, cerebral palsy and autism from China and more than 20 countries,More than 26800 childrens deformity returned to school and society and became self-sufficient.The rehabilitation effect ranks the international advanced level.Vice-chairman of Rehabilitation professional committe children with cerebral palsy,World Federation of Chinese Medicine Societies.Visiting Profassor of Chinese University of Hong Kong in recent 10 years. .He is most famous pediatric neurological and rehabilitation specialists in integrated traditional Chinese and Western medicine in China.He has edited 10 books.He has published 268 papers in international and Chinese medical journals.

Danilo Tagle is currently Director, Office of Special Initiatives at the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) where he leads efforts in developing innovative tools and technologies that can greatly accelerate development of diagnostics and therapeutics. These programs involve interdisciplinary collaborations between intramural and extramural components of NIH, and entail partnerships with other agencies, such as FDA, NASA, and DARPA, as well as with private sector. Some of the programs include tissue chips, 3D bioprinting, automated chemistry, electronic nose technology for disease diagnosis, quantum technologies, and the isolation and analyses of exosomes for biomarker and therapy development. He has served on numerous advisory and review committeesand editorial boards.He currently serves on the Biological and Physical Sciences Federal Advisory Committee, on the White House OSTP Microgravity Science and Technology Interagency Working Group, and servesas the point-of-contact for the liaison to the NASA/NIH/Department of Health and Human Services partnership. Dan obtained his PhD and MS in molecular biology and genetics from Wayne State University School of Medicine. He was an NIH National Research Service Award postdoctoral fellow in human genetics at the University of Michigan. Dan has authored many scientific publications and has garnered numerous awards, including more recently the Roscoe O. Brady Award for Innovation and Accomplishment; the Henry J. Heimlich Award for Innovative Medicine; the HHS Secretary's Award for Distinguished Service: Rapid Acceleration of Diagnostics (RADx) Initiative, and the NASA Silver Group Achievement Award.

Reem Al-Ahmad is a second year graduate student in the Dai Group. Her work focuses on the total synthesis of complex natural products and drug discovery. Reem earned her Bachelors degree from the University of Michigan. Her NSF proposal describes a project exploring the design and synthesis of novel non-addictive analgesics for treatment of chronic pain aimed to help alleviate the staggering healthcare and human costs of opioid addiction, rehabilitation, and treatment. “Reem always wants to develop innovative synthesis to directly impact biology and medicine,” says her primary research mentor, Dr. Mingji Dai. “She certainly has high standard and sharp mind about project selection. She is a patient hunter of high caliber and good taste.”